Efectividad de la vacuna VA-MENGOC-BC® contra cepas heterólogas de meningococo B / Effectiveness of VA-MENGOC-BC® vaccine against heterologous strains of meningococcus B
VacciMonitor
; 25(2)2016. tab
Article
in Es
| CUMED
| ID: cum-63025
Responsible library:
CU1.1
Localization: CU1.1
RESUMEN
La efectividad de las vacunas de vesículas de membrana externa de Neisseria meningitidis serogrupo B ha sido cuestionada por algunos investigadores, limitándola a la cepa vacunal. VA-MENGOC-BC® es una vacuna antimeningocócica basada en dicha tecnología. Presentamos un metaanálisis de estudios realizados en diferentes contextos epidemiológicos, evaluando su efectividad contra cepas heterólogas de meningococo B en varios grupos de edades. Se demuestra que la vacuna es efectiva contra cepas homólogas, heterólogas y de diferentes complejos clonales(AU)
ABSTRACT
Vaccines based on outer membrane vesicles of Neisseria meningitidis serogroup B strains have been questioned by some researchers, who limit its effectiveness to the vaccine strain. VA-MENGOC-BC® is a meningococcal vaccine based on this technology. A meta-analysis of independent studies in different epidemiological contexts is used to assess the clinical effectiveness of the vaccine against heterologous serogroup B strains in several age groups. In this paper we provide evidence supporting its effectiveness against homologous and heterologous strains from different clonal complexe(AU)
Key words
Full text:
1
Collection:
06-national
/
CU
Database:
CUMED
Main subject:
Meningococcal Vaccines
/
Meningitis, Meningococcal
Limits:
Humans
Language:
Es
Journal:
VacciMonitor
Year:
2016
Document type:
Article